NO20056175L - Metode for fremstilling av enantiomert ren mirtazapin - Google Patents
Metode for fremstilling av enantiomert ren mirtazapinInfo
- Publication number
- NO20056175L NO20056175L NO20056175A NO20056175A NO20056175L NO 20056175 L NO20056175 L NO 20056175L NO 20056175 A NO20056175 A NO 20056175A NO 20056175 A NO20056175 A NO 20056175A NO 20056175 L NO20056175 L NO 20056175L
- Authority
- NO
- Norway
- Prior art keywords
- enantiomerically pure
- mirtazapine
- acid
- preparing enantiomerically
- pure mirtazapine
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001785 mirtazapine Drugs 0.000 title abstract 3
- 239000002253 acid Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000007363 ring formation reaction Methods 0.000 abstract 2
- 239000003960 organic solvent Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03102095 | 2003-07-10 | ||
| PCT/EP2004/051357 WO2005005410A1 (en) | 2003-07-10 | 2004-07-05 | A method for the preparation of enantiomerically pure mirtazapine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20056175L true NO20056175L (no) | 2006-01-23 |
Family
ID=34042934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20056175A NO20056175L (no) | 2003-07-10 | 2005-12-23 | Metode for fremstilling av enantiomert ren mirtazapin |
Country Status (35)
| Country | Link |
|---|---|
| US (2) | US8058436B2 (is) |
| EP (1) | EP1656365B1 (is) |
| JP (1) | JP4668184B2 (is) |
| KR (1) | KR20060056315A (is) |
| CN (1) | CN100558722C (is) |
| AR (1) | AR046494A1 (is) |
| AT (1) | ATE433965T1 (is) |
| AU (1) | AU2004255874B2 (is) |
| BR (1) | BRPI0412447A (is) |
| CA (1) | CA2531165C (is) |
| CO (1) | CO5640123A2 (is) |
| CY (1) | CY1109327T1 (is) |
| DE (1) | DE602004021605D1 (is) |
| DK (1) | DK1656365T3 (is) |
| EC (1) | ECSP066271A (is) |
| ES (1) | ES2327123T3 (is) |
| HR (1) | HRP20051019A2 (is) |
| IL (1) | IL172549A0 (is) |
| IS (1) | IS2674B (is) |
| LT (1) | LT5382B (is) |
| LV (1) | LV13441B (is) |
| MX (1) | MXPA06000325A (is) |
| NO (1) | NO20056175L (is) |
| NZ (1) | NZ544360A (is) |
| PE (1) | PE20050323A1 (is) |
| PL (1) | PL1656365T3 (is) |
| PT (1) | PT1656365E (is) |
| RS (1) | RS20050972A (is) |
| RU (1) | RU2352566C2 (is) |
| SG (1) | SG144914A1 (is) |
| SI (1) | SI1656365T1 (is) |
| TW (1) | TWI335915B (is) |
| UA (1) | UA83666C2 (is) |
| WO (1) | WO2005005410A1 (is) |
| ZA (1) | ZA200600019B (is) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102126982A (zh) * | 2005-09-26 | 2011-07-20 | 住友化学株式会社 | 光学活性的哌嗪化合物的制造方法 |
| JP5080050B2 (ja) * | 2005-09-26 | 2012-11-21 | 住友化学株式会社 | 光学活性なピペラジン化合物の製造方法 |
| TW200808804A (en) * | 2006-05-22 | 2008-02-16 | Organon Nv | Mirtazapine for the treatment of neuropathic pain |
| TW200815370A (en) * | 2006-06-16 | 2008-04-01 | Organon Nv | Stereoselective synthesis of (S)-1-methyl-3-phenylpiperazine |
| US8273883B2 (en) * | 2007-02-09 | 2012-09-25 | Kaneka Corporation | Method for producing optically active 2-arylpiperazine derivative |
| JP5192707B2 (ja) * | 2007-03-22 | 2013-05-08 | 住友化学株式会社 | ミルタザピンの製造方法 |
| US7994314B2 (en) | 2007-04-11 | 2011-08-09 | N.V. Organon | Method for the preparation of an enantiomerically pure benzazepine |
| CN101679431B (zh) * | 2007-04-11 | 2013-08-14 | Msd欧斯股份有限公司 | 制备四环苯并氮杂卓的对映异构体的方法 |
| KR101485418B1 (ko) * | 2013-05-29 | 2015-01-26 | 주식회사 메디켐코리아 | 고순도 미르타자핀의 제조방법 |
| WO2016138357A1 (en) | 2015-02-27 | 2016-09-01 | Kindred Biosciences, Inc. | Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats |
| KR102540021B1 (ko) * | 2020-12-02 | 2023-06-07 | (주)유케이케미팜 | 대량 생산에 적합한 미르타자핀의 제조방법 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3959470A (en) * | 1972-11-28 | 1976-05-25 | Mikhail Davidovich Mashkovsky | Psychotropic medicinal preparation |
| NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
| CA2026925A1 (en) * | 1989-10-05 | 1991-04-06 | Hiroshi Fukumi | Tetracyclic compounds having anti-allergic and anti-asthmatic activities, their preparation and use |
| JPH11222407A (ja) * | 1997-11-14 | 1999-08-17 | Sankyo Co Ltd | 新規殺菌剤 |
| JP2001522891A (ja) | 1997-11-14 | 2001-11-20 | アクゾ・ノベル・エヌ・ベー | 睡眠時無呼吸を治療するためのミルタザピンの使用 |
| US20030069417A1 (en) * | 1999-04-19 | 2003-04-10 | Claude Singer | Novel synthesis and crystallization of piperazine ring-containing compounds |
| CA2368815A1 (en) * | 1999-04-19 | 2000-10-26 | Claude Singer | Novel synthesis and crystallization of piperazine ring-containing compounds |
| US6068695A (en) * | 1999-07-13 | 2000-05-30 | Bayer Corporation | Process for the continuous preparation of quinacridones |
| AU6476300A (en) | 1999-09-30 | 2001-05-10 | Sumika Fine Chemicals Co., Ltd. | Process for the preparation of a piperazine derivative |
| AU6474200A (en) * | 1999-12-13 | 2001-06-18 | Sumika Fine Chemicals Co., Ltd. | Process for the preparation of a pyridinemethanol compound |
| BR0108261A (pt) | 2000-02-11 | 2003-03-05 | Akzo Nobel Nv | Uso de mirtazapina, método de tratamento de um distúrbio do sono em um indivìduo, e, kit para paciente para o tratamento de distúrbios do sono |
| JP2001342188A (ja) * | 2000-03-27 | 2001-12-11 | Takeda Chem Ind Ltd | 縮合ピラゾール誘導体、その製造法および用途 |
| TW200538100A (en) * | 2004-04-21 | 2005-12-01 | Akzo Nobel Nv | Mirtazapine salts |
-
2004
- 2004-05-07 UA UAA200600274A patent/UA83666C2/ru unknown
- 2004-06-28 TW TW093118845A patent/TWI335915B/zh not_active IP Right Cessation
- 2004-07-05 WO PCT/EP2004/051357 patent/WO2005005410A1/en not_active Ceased
- 2004-07-05 BR BRPI0412447-2A patent/BRPI0412447A/pt not_active IP Right Cessation
- 2004-07-05 PL PL04741958T patent/PL1656365T3/pl unknown
- 2004-07-05 AU AU2004255874A patent/AU2004255874B2/en not_active Expired
- 2004-07-05 CA CA2531165A patent/CA2531165C/en not_active Expired - Fee Related
- 2004-07-05 PT PT04741958T patent/PT1656365E/pt unknown
- 2004-07-05 ES ES04741958T patent/ES2327123T3/es not_active Expired - Lifetime
- 2004-07-05 EP EP04741958A patent/EP1656365B1/en not_active Expired - Lifetime
- 2004-07-05 MX MXPA06000325A patent/MXPA06000325A/es active IP Right Grant
- 2004-07-05 RU RU2006103992/04A patent/RU2352566C2/ru not_active IP Right Cessation
- 2004-07-05 DK DK04741958T patent/DK1656365T3/da active
- 2004-07-05 JP JP2006518216A patent/JP4668184B2/ja not_active Expired - Lifetime
- 2004-07-05 KR KR1020067000511A patent/KR20060056315A/ko not_active Abandoned
- 2004-07-05 AT AT04741958T patent/ATE433965T1/de active
- 2004-07-05 RS YUP-2005/0972A patent/RS20050972A/sr unknown
- 2004-07-05 US US10/564,193 patent/US8058436B2/en not_active Expired - Fee Related
- 2004-07-05 NZ NZ544360A patent/NZ544360A/en not_active IP Right Cessation
- 2004-07-05 DE DE602004021605T patent/DE602004021605D1/de not_active Expired - Lifetime
- 2004-07-05 HR HR20051019A patent/HRP20051019A2/xx not_active Application Discontinuation
- 2004-07-05 SG SG200805127-8A patent/SG144914A1/en unknown
- 2004-07-05 CN CNB2004800194891A patent/CN100558722C/zh not_active Expired - Lifetime
- 2004-07-05 SI SI200431183T patent/SI1656365T1/sl unknown
- 2004-07-07 PE PE2004000653A patent/PE20050323A1/es not_active Application Discontinuation
- 2004-07-08 AR ARP040102412A patent/AR046494A1/es not_active Application Discontinuation
-
2005
- 2005-12-12 LT LT2005107A patent/LT5382B/lt not_active IP Right Cessation
- 2005-12-13 IL IL172549A patent/IL172549A0/en not_active IP Right Cessation
- 2005-12-15 IS IS8184A patent/IS2674B/is unknown
- 2005-12-23 NO NO20056175A patent/NO20056175L/no not_active Application Discontinuation
-
2006
- 2006-01-03 ZA ZA200600019A patent/ZA200600019B/en unknown
- 2006-01-09 EC EC2006006271A patent/ECSP066271A/es unknown
- 2006-01-10 CO CO06001617A patent/CO5640123A2/es not_active Application Discontinuation
- 2006-02-10 LV LVP-06-21A patent/LV13441B/en unknown
-
2008
- 2008-07-02 US US12/667,969 patent/US20100179319A1/en not_active Abandoned
-
2009
- 2009-08-25 CY CY20091100894T patent/CY1109327T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20056175L (no) | Metode for fremstilling av enantiomert ren mirtazapin | |
| PE20050078A1 (es) | Derivados de pirrolidona como inhibidores de maob | |
| TW200510381A (en) | Novel 2-pyridinecarboxamide derivatives | |
| SE9904850D0 (sv) | Novel process and intermediates | |
| IN2014MN02582A (is) | ||
| DE60230630D1 (de) | Schwarzes perylenpigment und verfahren zu dessen herstellung | |
| DE602005011609D1 (de) | Verbessertes verfahren zur herstellung von 3-hydroxy-4-hydroxymethyl-pyrrolidin-verbindungen | |
| UA85196C2 (ru) | Способ получения сульфоксида в виде отдельного энантиомера или энантиомерно обогащенной формы | |
| ATE422200T1 (de) | Verfahren zur herstellung substituierter nikotinsäureester | |
| NO20076000L (no) | Aminosyrederivater | |
| MXPA04004063A (es) | Procedimientos para elaboracion de 3-hidroxi-n, 1, 6-trialquil-4 -oxo-1 ,4-dihidropiridin-2 -carboxamida. | |
| TW200504025A (en) | Organic compounds | |
| ATE518864T1 (de) | Verfahren zur herstellung von carbapenemverbindungen | |
| DE60006857D1 (de) | Verfahren zur herstellung von pyridinmethanol-verbindungen | |
| NO20075224L (no) | Prosess og fremgangsmater for fremstilling av optisk aktiv CIS-2-hydroxymethyl-4-(cytosin-1'-YL)-1,3 oxathiolan eller farmasoytisk akseptable salter derav | |
| NO20074438L (no) | Fremgangsmate for enantioselektiv syntese av enkeltenantiomerer av tio-substituerte arylmetansulfinylderivater fra asymmetriske oksidasjon | |
| ATE256108T1 (de) | Verfahren zur herstellung von cholecalciferol- derivaten und zwischenverbindungen | |
| EE05136B1 (et) | Asendatud imidasopridiinhendite valmistamise meetod | |
| ATE279191T1 (de) | Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel | |
| NO20054456L (no) | Fremgangsmate for fremstilling av enantiomere former av cis-konfigurerte 1,3-cykloheksandiolderivater | |
| UA85428C2 (ru) | Способ получения с-2, с-3 замещенных n-алкилированных индолов, а также промежуточные соединения и способы их получения | |
| ATE244706T1 (de) | Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung | |
| TW200502197A (en) | Process for producing enantiopure β-amino acid derivatives, and enantiopureβ-amino acid derivatives | |
| NO20010802L (no) | Nye aryl- eller heteroarylkinolylfosfonsyreforbindelser, en fremgangsmåte ved deres fremstilling og sammensetningerinneholdende dem | |
| TW200800955A (en) | Improved process for preparing insecticidal (disubstitutedpropenyl) phenylalkyl substituted heterocycles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |